{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:23:12Z","timestamp":1773300192343,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T00:00:00Z","timestamp":1344556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2407-12-350","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T12:17:46Z","timestamp":1344601066000},"source":"Crossref","is-referenced-by-count":15,"title":["The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors"],"prefix":"10.1186","volume":"12","author":[{"given":"Elisabet","family":"Tina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breezy Malakkaran","family":"Lindqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marike","family":"Gabrielson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zelmina","family":"Lubovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Wegman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sten","family":"Wingren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,10]]},"reference":[{"issue":"4785","key":"3269_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science. 1987, 235 (4785): 177-182. 10.1126\/science.3798106.","journal-title":"Science"},{"issue":"1","key":"3269_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1677\/erc.0.0080011","volume":"8","author":"N Prenzel","year":"2001","unstructured":"Prenzel N, Fischer OM, Streit S, Hart S, Ullrich A: The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer. 2001, 8 (1): 11-31. 10.1677\/erc.0.0080011.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"3269_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3816\/CBC.2004.n.011","volume":"5","author":"MA Owens","year":"2004","unstructured":"Owens MA, Horten BC, Da Silva MM: HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin Breast Cancer. 2004, 5 (1): 63-69. 10.3816\/CBC.2004.n.011.","journal-title":"Clin Breast Cancer"},{"issue":"8","key":"3269_CR4","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1200\/JCO.1997.15.8.2894","volume":"15","author":"MF Press","year":"1997","unstructured":"Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, et al: HER-2\/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997, 15 (8): 2894-2904.","journal-title":"J Clin Oncol"},{"issue":"11","key":"3269_CR5","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1002\/1097-0142(19941201)74:11<2956::AID-CNCR2820741111>3.0.CO;2-V","volume":"74","author":"LC Hartmann","year":"1994","unstructured":"Hartmann LC, Ingle JN, Wold LE, Farr GH, Grill JP, Su JQ, Maihle NJ, Krook JE, Witzig TE, Roche PC: Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol. Cancer. 1994, 74 (11): 2956-2963. 10.1002\/1097-0142(19941201)74:11<2956::AID-CNCR2820741111>3.0.CO;2-V.","journal-title":"Cancer"},{"key":"3269_CR6","first-page":"155","volume":"1","author":"E Lantz","year":"2010","unstructured":"Lantz E, Cunningham I, Higa GM: Targeting HER2 in breast cancer: overview of long-term experience. Int J Womens Health. 2010, 1: 155-171.","journal-title":"Int J Womens Health"},{"issue":"11","key":"3269_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, et al: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001, 344 (11): 783-792. 10.1056\/NEJM200103153441101.","journal-title":"N Engl J Med"},{"issue":"9555","key":"3269_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(07)60028-2","volume":"369","author":"I Smith","year":"2007","unstructured":"Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, Goldhirsch A, Untch M, Mariani G, Baselga J, et al: 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet. 2007, 369 (9555): 29-36. 10.1016\/S0140-6736(07)60028-2.","journal-title":"Lancet"},{"issue":"7","key":"3269_CR9","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1200\/JCO.2002.07.058","volume":"20","author":"FJ Esteva","year":"2002","unstructured":"Esteva FJ, Valero V, Booser D, Guerra LT, Murray JL, Pusztai L, Cristofanilli M, Arun B, Esmaeli B, Fritsche HA, et al: Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. J Clin Oncol. 2002, 20 (7): 1800-1808. 10.1200\/JCO.2002.07.058.","journal-title":"J Clin Oncol"},{"key":"3269_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","volume":"4","author":"N Chalhoub","year":"2009","unstructured":"Chalhoub N, Baker SJ: PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol. 2009, 4: 127-150. 10.1146\/annurev.pathol.4.110807.092311.","journal-title":"Annu Rev Pathol"},{"issue":"5308","key":"3269_CR11","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997, 275 (5308): 1943-1947. 10.1126\/science.275.5308.1943.","journal-title":"Science"},{"key":"3269_CR12","first-page":"147","volume":"222","author":"R Parsons","year":"2003","unstructured":"Parsons R, Simpson L: PTEN and cancer. Methods Mol Biol. 2003, 222: 147-166.","journal-title":"Methods Mol Biol"},{"key":"3269_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2407-11-11","volume":"11","author":"L Wang","year":"2011","unstructured":"Wang L, Zhang Q, Zhang J, Sun S, Guo H, Jia Z, Wang B, Shao Z, Wang Z, Hu X: PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib. BMC Cancer. 2011, 11: 11-248. 10.1186\/1471-2407-11-11.","journal-title":"BMC Cancer"},{"issue":"2","key":"3269_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ccr.2004.06.022","volume":"6","author":"Y Nagata","year":"2004","unstructured":"Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, et al: PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell. 2004, 6 (2): 117-127. 10.1016\/j.ccr.2004.06.022.","journal-title":"Cancer Cell"},{"issue":"5","key":"3269_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/cyto.990030503","volume":"3","author":"LL Vindelov","year":"1983","unstructured":"Vindelov LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983, 3 (5): 323-327. 10.1002\/cyto.990030503.","journal-title":"Cytometry"},{"issue":"7","key":"3269_CR16","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/bioinformatics\/bti141","volume":"21","author":"G Caraux","year":"2005","unstructured":"Caraux G, Pinloche S: PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics. 2005, 21 (7): 1280-1281. 10.1093\/bioinformatics\/bti141.","journal-title":"Bioinformatics"},{"issue":"5","key":"3269_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00424-003-1099-7","volume":"447","author":"F Palmieri","year":"2004","unstructured":"Palmieri F: The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch. 2004, 447 (5): 689-709. 10.1007\/s00424-003-1099-7.","journal-title":"Pflugers Arch"},{"issue":"6","key":"3269_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ygeno.2006.06.016","volume":"88","author":"T Haitina","year":"2006","unstructured":"Haitina T, Lindblom J, Renstrom T, Fredriksson R: Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. Genomics. 2006, 88 (6): 779-790. 10.1016\/j.ygeno.2006.06.016.","journal-title":"Genomics"},{"issue":"3","key":"3269_CR19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/pro.320","volume":"19","author":"A Schlessinger","year":"2010","unstructured":"Schlessinger A, Matsson P, Shima JE, Pieper U, Yee SW, Kelly L, Apeltsin L, Stroud RM, Ferrin TE, Giacomini KM, et al: Comparison of human solute carriers. Protein Sci. 2010, 19 (3): 412-428.","journal-title":"Protein Sci"},{"issue":"1","key":"3269_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s003359900007","volume":"7","author":"JW Ellison","year":"1996","unstructured":"Ellison JW, Li X, Francke U, Shapiro LJ: Rapid evolution of human pseudoautosomal genes and their mouse homologs. Mamm Genome. 1996, 7 (1): 25-30. 10.1007\/s003359900007.","journal-title":"Mamm Genome"},{"issue":"46","key":"3269_CR21","doi-asserted-by":"publisher","first-page":"17766","DOI":"10.1073\/pnas.0809580105","volume":"105","author":"AJ Robinson","year":"2008","unstructured":"Robinson AJ, Overy C, Kunji ER: The mechanism of transport by mitochondrial carriers based on analysis of symmetry. Proc Natl Acad Sci U S A. 2008, 105 (46): 17766-17771. 10.1073\/pnas.0809580105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3269_CR22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971, 68 (4): 820-823. 10.1073\/pnas.68.4.820.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3269_CR23","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/bcr3075","volume":"13","author":"J Staaf","year":"2011","unstructured":"Staaf J, Jonsson G, Ringner M, Baldetorp B, Borg A: Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer. Breast Cancer Res. 2011, 13 (6): R129-10.1186\/bcr3075.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"3269_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10549-010-1297-x","volume":"127","author":"LW Loo","year":"2011","unstructured":"Loo LW, Wang Y, Flynn EM, Lund MJ, Bowles EJ, Buist DS, Liff JM, Flagg EW, Coates RJ, Eley JW, et al: Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women. Breast Cancer Res Treat. 2011, 127 (1): 297-308. 10.1007\/s10549-010-1297-x.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3269_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/gcc.10024","volume":"33","author":"Z Piao","year":"2002","unstructured":"Piao Z, Malkhosyan SR: Frequent loss Xq25 on the inactive X chromosome in primary breast carcinomas is associated with tumor grade and axillary lymph node metastasis. Genes Chromosomes Cancer. 2002, 33 (3): 262-269. 10.1002\/gcc.10024.","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"3269_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones PA, Baylin SB: The epigenomics of cancer. Cell. 2007, 128 (4): 683-692. 10.1016\/j.cell.2007.01.029.","journal-title":"Cell"},{"issue":"10","key":"3269_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nbt.1685","volume":"28","author":"A Portela","year":"2010","unstructured":"Portela A, Esteller M: Epigenetic modifications and human disease. Nat Biotechnol. 2010, 28 (10): 1057-1068. 10.1038\/nbt.1685.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"3269_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4161\/epi.7.3.19064","volume":"7","author":"BM Lindqvist","year":"2012","unstructured":"Lindqvist BM, Farkas SA, Wingren S, Nilsson TK: DNA methylation pattern of the SLC25A43 gene in breast cancer. Epigenetics. 2012, 7 (3): 300-306. 10.4161\/epi.7.3.19064.","journal-title":"Epigenetics"},{"issue":"8","key":"3269_CR29","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/jnci\/88.8.480","volume":"88","author":"CJ Brown","year":"1996","unstructured":"Brown CJ: Role of the X chromosome in cancer. J Natl Cancer Inst. 1996, 88 (8): 480-482. 10.1093\/jnci\/88.8.480.","journal-title":"J Natl Cancer Inst"},{"issue":"29","key":"3269_CR30","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1073\/pnas.0904875106","volume":"106","author":"K Mitra","year":"2009","unstructured":"Mitra K, Wunder C, Roysam B, Lin G, Lippincott-Schwartz J: A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc Natl Acad Sci U S A. 2009, 106 (29): 11960-11965. 10.1073\/pnas.0904875106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"3269_CR31","doi-asserted-by":"publisher","first-page":"18152","DOI":"10.1074\/jbc.M109.014118","volume":"284","author":"G Fiermonte","year":"2009","unstructured":"Fiermonte G, Paradies E, Todisco S, Marobbio CM, Palmieri F: A novel member of solute carrier family 25 (SLC25A42) is a transporter of coenzyme A and adenosine 3',5'-diphosphate in human mitochondria. J Biol Chem. 2009, 284 (27): 18152-18159. 10.1074\/jbc.M109.014118.","journal-title":"J Biol Chem"},{"issue":"6","key":"3269_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E: The Metabolism of Tumors in the Body. J Gen Physiol. 1927, 8 (6): 519-530. 10.1085\/jgp.8.6.519.","journal-title":"J Gen Physiol"},{"issue":"5","key":"3269_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144 (5): 646-674. 10.1016\/j.cell.2011.02.013.","journal-title":"Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-350\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T04:44:55Z","timestamp":1643172295000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3269"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-350","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,10]]},"article-number":"350"}}